Conquering the number one killer of Minnesotans is no easy task.
Studies in genetics, cell and vaccine therapies, immunology, and blood and marrow transplantation combine with the University's specialized cell processing facilities to provide innovative treatments to conquer this killer.
Home to the Masonic Cancer Center – the Twin Cities’ only National Cancer Institute-designated comprehensive cancer center – we have the depth and breadth in research and care to reduce the toll of this deadly disease.
Nelson Rhodus
Nelson Rhodus studies how DNA in cells in saliva may predict if a person is at risk for developing oral cancer in order to one day eliminate invasive biopsies.
From the AHC
U of M researchers identify genetic variation behind acute myeloid leukemia treatment success
Pharmacy and Medical School researchers within the Masonic Cancer Center, partnered to make the discovery
-
MN Partnership Researchers Uncover Cancer Drug Prospects
02/25/13
Clues to possible drugs for two rare cancers through research involving baker's yeast and a library of chemical compounds were uncovered
-
Masonic Cancer Center researchers discover enzyme behind breast cancer mutations
02/06/13
The discovery may change the way breast cancer is diagnosed and treated
-
U of M researchers develop new drug to target and destroy tumor cells
10/17/12
A new drug developed by researchers at the University of Minnesota Medical School may hold the answer to defeating pancreatic cancer.
